# DEXTENZA in Pediatric Patients Following Retinal Surgery or Laser Treatment Under Anesthesia

> **NCT05620901** · EARLY_PHASE1 · COMPLETED · sponsor: **Lejla Vajzovic, MD, FASRS** · enrollment: 15 (actual)

## Conditions studied

- Vitreoretinopathy
- Coats' Disease
- Exudative Retinopathy
- Lattice Degeneration
- Retinal Hole
- Sickler's Syndrome
- Retinal Detachment Rhegmatogenous
- Retinal Detachment Exudative
- Retinal Detachment Traction

## Interventions

- **DRUG:** Dextenza 0.4Mg Ophthalmic Insert
- **DRUG:** Pred Forte

## Key facts

- **NCT ID:** NCT05620901
- **Lead sponsor:** Lejla Vajzovic, MD, FASRS
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-01
- **Primary completion:** 2025-02-11
- **Final completion:** 2025-02-24
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05620901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05620901, "DEXTENZA in Pediatric Patients Following Retinal Surgery or Laser Treatment Under Anesthesia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05620901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*